How much is the Gene Therapy Market market?

The gene therapy market market size is estimated to grow at $$ 6738 mn in 2023. Read More

What is the growth rate of the Gene Therapy Market market?

The growth rate of the gene therapy market year-over-year is 23.31%. Read More

Which region held the largest market share in the Gene Therapy Market market?

North America is the region to held the largest market share with 40% growth. Read More

Who are the key players in the Gene Therapy Market market?

Astellas Pharma Inc., bluebird bio, Inc., CRISPR Therapeutics AG, Gilead Sciences, Inc., Kite Pharma (Gilead Sciences), Novartis AG, Orchard Therapeutics plc, Pfizer Inc., RegenXBio Inc., .... Read More

Which Segment has the largest market share in the Gene Therapy Market market?

Delivery Mode is the segment that has the largest market share in the market. Read More

Gene Therapy Market Analysis, Size, and Forecast 2024-2028: North America (US and Canada), Europe (France, Germany, Italy, and UK), Middle East and Africa (Egypt, KSA, Oman, and UAE), APAC (China, India, and Japan), South America (Argentina and Brazil), and Rest of World (ROW)

Published: Jun 2024
Pages: 177
SKU: IRTNTR73059

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Delivery Mode
- Executive Summary - Chart on Market Segmentation by Therapy Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Gene Therapy Market 2018 - 2022
- Historic Market Size - Data Table on Global Gene Therapy Market 2018 - 2022 ($ million)

4.2 Delivery Mode segment analysis 2018 - 2022
- Historic Market Size - Delivery Mode Segment 2018 - 2022 ($ million)

4.3 Therapy Area segment analysis 2018 - 2022
- Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)

4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Delivery Mode

6.1 Market segments
- Chart on Delivery Mode - Market share (2023-2028) (%)
- Data Table on Delivery Mode - Market share (2023-2028) (%)

6.2 Comparison by Delivery Mode
- Chart on Comparison by Delivery Mode
- Data Table on Comparison by Delivery Mode

6.3 In vivo - Market size and forecast (2023-2028)
- Chart on In vivo - Market size and forecast (2023-2028) ($ million)
- Data Table on In vivo - Market size and forecast (2023-2028) ($ million)
- Chart on In vivo - Year-over-year growth (2023-2028) (%)
- Data Table on In vivo - Year-over-year growth (2023-2028) (%)

6.4 Ex vivo - Market size and forecast (2023-2028)
- Chart on Ex vivo - Market size and forecast (2023-2028) ($ million)
- Data Table on Ex vivo - Market size and forecast (2023-2028) ($ million)
- Chart on Ex vivo - Year-over-year growth (2023-2028) (%)
- Data Table on Ex vivo - Year-over-year growth (2023-2028) (%)

6.5 Market opportunity by Delivery Mode
- Market opportunity by Delivery Mode ($ million)
- Data Table on Market opportunity by Delivery Mode ($ million)

7 Market Segmentation by Therapy Area

7.1 Market segments
- Chart on Therapy Area - Market share (2023-2028) (%)
- Data Table on Therapy Area - Market share (2023-2028) (%)

7.2 Comparison by Therapy Area
- Chart on Comparison by Therapy Area
- Data Table on Comparison by Therapy Area

7.3 Oncology - Market size and forecast (2023-2028)
- Chart on Oncology - Market size and forecast (2023-2028) ($ million)
- Data Table on Oncology - Market size and forecast (2023-2028) ($ million)
- Chart on Oncology - Year-over-year growth (2023-2028) (%)
- Data Table on Oncology - Year-over-year growth (2023-2028) (%)

7.4 CNS - Market size and forecast (2023-2028)
- Chart on CNS - Market size and forecast (2023-2028) ($ million)
- Data Table on CNS - Market size and forecast (2023-2028) ($ million)
- Chart on CNS - Year-over-year growth (2023-2028) (%)
- Data Table on CNS - Year-over-year growth (2023-2028) (%)

7.5 Ophthalmology - Market size and forecast (2023-2028)
- Chart on Ophthalmology - Market size and forecast (2023-2028) ($ million)
- Data Table on Ophthalmology - Market size and forecast (2023-2028) ($ million)
- Chart on Ophthalmology - Year-over-year growth (2023-2028) (%)
- Data Table on Ophthalmology - Year-over-year growth (2023-2028) (%)

7.6 Rare diseases - Market size and forecast (2023-2028)
- Chart on Rare diseases - Market size and forecast (2023-2028) ($ million)
- Data Table on Rare diseases - Market size and forecast (2023-2028) ($ million)
- Chart on Rare diseases - Year-over-year growth (2023-2028) (%)
- Data Table on Rare diseases - Year-over-year growth (2023-2028) (%)

7.7 Others - Market size and forecast (2023-2028)
- Chart on Others - Market size and forecast (2023-2028) ($ million)
- Data Table on Others - Market size and forecast (2023-2028) ($ million)
- Chart on Others - Year-over-year growth (2023-2028) (%)
- Data Table on Others - Year-over-year growth (2023-2028) (%)

7.8 Market opportunity by Therapy Area
- Market opportunity by Therapy Area ($ million)
- Data Table on Market opportunity by Therapy Area ($ million)

8 Market Segmentation by Vector Type

8.1 Market segments
- Chart on Vector Type - Market share (2023-2028) (%)
- Data Table on Vector Type - Market share (2023-2028) (%)

8.2 Comparison by Vector Type
- Chart on Comparison by Vector Type
- Data Table on Comparison by Vector Type

8.3 Viral Vectors - Market size and forecast (2023-2028)
- Chart on Viral Vectors - Market size and forecast (2023-2028) ($ million)
- Data Table on Viral Vectors - Market size and forecast (2023-2028) ($ million)
- Chart on Viral Vectors - Year-over-year growth (2023-2028) (%)
- Data Table on Viral Vectors - Year-over-year growth (2023-2028) (%)

8.4 Non-viral Vectors - Market size and forecast (2023-2028)
- Chart on Non-viral Vectors - Market size and forecast (2023-2028) ($ million)
- Data Table on Non-viral Vectors - Market size and forecast (2023-2028) ($ million)
- Chart on Non-viral Vectors - Year-over-year growth (2023-2028) (%)
- Data Table on Non-viral Vectors - Year-over-year growth (2023-2028) (%)

8.5 Market opportunity by Vector Type
- Market opportunity by Vector Type ($ million)
- Data Table on Market opportunity by Vector Type ($ million)

9 Market Segmentation by Indication

9.1 Market segments
- Chart on Indication - Market share (2023-2028) (%)
- Data Table on Indication - Market share (2023-2028) (%)

9.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication

9.3 Genetic Disorders - Market size and forecast (2023-2028)
- Chart on Genetic Disorders - Market size and forecast (2023-2028) ($ million)
- Data Table on Genetic Disorders - Market size and forecast (2023-2028) ($ million)
- Chart on Genetic Disorders - Year-over-year growth (2023-2028) (%)
- Data Table on Genetic Disorders - Year-over-year growth (2023-2028) (%)

9.4 Cancer - Market size and forecast (2023-2028)
- Chart on Cancer - Market size and forecast (2023-2028) ($ million)
- Data Table on Cancer - Market size and forecast (2023-2028) ($ million)
- Chart on Cancer - Year-over-year growth (2023-2028) (%)
- Data Table on Cancer - Year-over-year growth (2023-2028) (%)

9.5 Infectious Diseases - Market size and forecast (2023-2028)
- Chart on Infectious Diseases - Market size and forecast (2023-2028) ($ million)
- Data Table on Infectious Diseases - Market size and forecast (2023-2028) ($ million)
- Chart on Infectious Diseases - Year-over-year growth (2023-2028) (%)
- Data Table on Infectious Diseases - Year-over-year growth (2023-2028) (%)

9.6 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

10 Market Segmentation by Application

10.1 Market segments
- Chart on Application - Market share (2023-2028) (%)
- Data Table on Application - Market share (2023-2028) (%)

10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application

10.3 Oncology - Market size and forecast (2023-2028)
- Chart on Oncology - Market size and forecast (2023-2028) ($ million)
- Data Table on Oncology - Market size and forecast (2023-2028) ($ million)
- Chart on Oncology - Year-over-year growth (2023-2028) (%)
- Data Table on Oncology - Year-over-year growth (2023-2028) (%)

10.4 Orphan Diseases - Market size and forecast (2023-2028)
- Chart on Orphan Diseases - Market size and forecast (2023-2028) ($ million)
- Data Table on Orphan Diseases - Market size and forecast (2023-2028) ($ million)
- Chart on Orphan Diseases - Year-over-year growth (2023-2028) (%)
- Data Table on Orphan Diseases - Year-over-year growth (2023-2028) (%)

10.5 Neurological Disorders - Market size and forecast (2023-2028)
- Chart on Neurological Disorders - Market size and forecast (2023-2028) ($ million)
- Data Table on Neurological Disorders - Market size and forecast (2023-2028) ($ million)
- Chart on Neurological Disorders - Year-over-year growth (2023-2028) (%)
- Data Table on Neurological Disorders - Year-over-year growth (2023-2028) (%)

10.6 Cardiovascular Diseases - Market size and forecast (2023-2028)
- Chart on Cardiovascular Diseases - Market size and forecast (2023-2028) ($ million)
- Data Table on Cardiovascular Diseases - Market size and forecast (2023-2028) ($ million)
- Chart on Cardiovascular Diseases - Year-over-year growth (2023-2028) (%)
- Data Table on Cardiovascular Diseases - Year-over-year growth (2023-2028) (%)

10.7 Infectious Diseases - Market size and forecast (2023-2028)
- Chart on Infectious Diseases - Market size and forecast (2023-2028) ($ million)
- Data Table on Infectious Diseases - Market size and forecast (2023-2028) ($ million)
- Chart on Infectious Diseases - Year-over-year growth (2023-2028) (%)
- Data Table on Infectious Diseases - Year-over-year growth (2023-2028) (%)

10.8 Hematological Disorders - Market size and forecast (2023-2028)
- Chart on Hematological Disorders - Market size and forecast (2023-2028) ($ million)
- Data Table on Hematological Disorders - Market size and forecast (2023-2028) ($ million)
- Chart on Hematological Disorders - Year-over-year growth (2023-2028) (%)
- Data Table on Hematological Disorders - Year-over-year growth (2023-2028) (%)

10.9 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

12.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

12.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

12.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

12.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

12.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

12.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

12.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

12.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

12.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)

12.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

12.13 Germany - Market size and forecast (2023-2028)
- Chart on Germany - Market size and forecast (2023-2028) ($ million)
- Data Table on Germany - Market size and forecast (2023-2028) ($ million)
- Chart on Germany - Year-over-year growth (2023-2028) (%)
- Data Table on Germany - Year-over-year growth (2023-2028) (%)

12.14 Italy - Market size and forecast (2023-2028)
- Chart on Italy - Market size and forecast (2023-2028) ($ million)
- Data Table on Italy - Market size and forecast (2023-2028) ($ million)
- Chart on Italy - Year-over-year growth (2023-2028) (%)
- Data Table on Italy - Year-over-year growth (2023-2028) (%)

12.15 France - Market size and forecast (2023-2028)
- Chart on France - Market size and forecast (2023-2028) ($ million)
- Data Table on France - Market size and forecast (2023-2028) ($ million)
- Chart on France - Year-over-year growth (2023-2028) (%)
- Data Table on France - Year-over-year growth (2023-2028) (%)

12.16 India - Market size and forecast (2023-2028)
- Chart on India - Market size and forecast (2023-2028) ($ million)
- Data Table on India - Market size and forecast (2023-2028) ($ million)
- Chart on India - Year-over-year growth (2023-2028) (%)
- Data Table on India - Year-over-year growth (2023-2028) (%)

12.17 Brazil - Market size and forecast (2023-2028)
- Chart on Brazil - Market size and forecast (2023-2028) ($ million)
- Data Table on Brazil - Market size and forecast (2023-2028) ($ million)
- Chart on Brazil - Year-over-year growth (2023-2028) (%)
- Data Table on Brazil - Year-over-year growth (2023-2028) (%)

12.18 Egypt - Market size and forecast (2023-2028)
- Chart on Egypt - Market size and forecast (2023-2028) ($ million)
- Data Table on Egypt - Market size and forecast (2023-2028) ($ million)
- Chart on Egypt - Year-over-year growth (2023-2028) (%)
- Data Table on Egypt - Year-over-year growth (2023-2028) (%)

12.19 UAE - Market size and forecast (2023-2028)
- Chart on UAE - Market size and forecast (2023-2028) ($ million)
- Data Table on UAE - Market size and forecast (2023-2028) ($ million)
- Chart on UAE - Year-over-year growth (2023-2028) (%)
- Data Table on UAE - Year-over-year growth (2023-2028) (%)

12.20 Oman - Market size and forecast (2023-2028)
- Chart on Oman - Market size and forecast (2023-2028) ($ million)
- Data Table on Oman - Market size and forecast (2023-2028) ($ million)
- Chart on Oman - Year-over-year growth (2023-2028) (%)
- Data Table on Oman - Year-over-year growth (2023-2028) (%)

12.21 Argentina - Market size and forecast (2023-2028)
- Chart on Argentina - Market size and forecast (2023-2028) ($ million)
- Data Table on Argentina - Market size and forecast (2023-2028) ($ million)
- Chart on Argentina - Year-over-year growth (2023-2028) (%)
- Data Table on Argentina - Year-over-year growth (2023-2028) (%)

12.22 KSA - Market size and forecast (2023-2028)
- Chart on KSA - Market size and forecast (2023-2028) ($ million)
- Data Table on KSA - Market size and forecast (2023-2028) ($ million)
- Chart on KSA - Year-over-year growth (2023-2028) (%)
- Data Table on KSA - Year-over-year growth (2023-2028) (%)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers

13.2 Market challenges

13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview

14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption
- Overview on factors of disruption

14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered

15.2 Market positioning of companies
- Matrix on companies position and classification

15.3 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings

15.4 bluebird bio, Inc.
- bluebird bio, Inc. - Overview
- bluebird bio, Inc. - Product / Service
- bluebird bio, Inc. - Key offerings

15.5 CRISPR Therapeutics AG
- CRISPR Therapeutics AG - Overview
- CRISPR Therapeutics AG - Product / Service
- CRISPR Therapeutics AG - Key offerings

15.6 Gilead Sciences, Inc.
- Gilead Sciences, Inc. - Overview
- Gilead Sciences, Inc. - Product / Service
- Gilead Sciences, Inc. - Key offerings

15.7 Kite Pharma (Gilead Sciences)
- Kite Pharma (Gilead Sciences) - Overview
- Kite Pharma (Gilead Sciences) - Product / Service
- Kite Pharma (Gilead Sciences) - Key offerings

15.8 Novartis AG
- Novartis AG - Overview
- Novartis AG - Product / Service
- Novartis AG - Key offerings

15.9 Orchard Therapeutics plc
- Orchard Therapeutics plc - Overview
- Orchard Therapeutics plc - Product / Service
- Orchard Therapeutics plc - Key offerings

15.10 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key offerings

15.11 RegenXBio Inc.
- RegenXBio Inc. - Overview
- RegenXBio Inc. - Product / Service
- RegenXBio Inc. - Key offerings

15.12 Roche Holding AG
- Roche Holding AG - Overview
- Roche Holding AG - Product / Service
- Roche Holding AG - Key offerings

15.13 Sarepta Therapeutics, Inc.
- Sarepta Therapeutics, Inc. - Overview
- Sarepta Therapeutics, Inc. - Product / Service
- Sarepta Therapeutics, Inc. - Key offerings

15.14 Spark Therapeutics (Roche)
- Spark Therapeutics (Roche) - Overview
- Spark Therapeutics (Roche) - Product / Service
- Spark Therapeutics (Roche) - Key offerings

15.15 uniQure N.V.
- uniQure N.V. - Overview
- uniQure N.V. - Product / Service
- uniQure N.V. - Key offerings

15.16 Voyager Therapeutics, Inc.
- Voyager Therapeutics, Inc. - Overview
- Voyager Therapeutics, Inc. - Product / Service
- Voyager Therapeutics, Inc. - Key offerings

15.17 VBL Therapeutics
- VBL Therapeutics - Overview
- VBL Therapeutics - Product / Service
- VBL Therapeutics - Key offerings

15.18 Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Incorporated - Overview
- Vertex Pharmaceuticals Incorporated - Product / Service
- Vertex Pharmaceuticals Incorporated - Key offerings

15.19 Xencor, Inc.
- Xencor, Inc. - Overview
- Xencor, Inc. - Product / Service
- Xencor, Inc. - Key offerings

15.20 Sangamo Therapeutics, Inc.
- Sangamo Therapeutics, Inc. - Overview
- Sangamo Therapeutics, Inc. - Product / Service
- Sangamo Therapeutics, Inc. - Key offerings

15.21 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings

15.22 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings

15.23 Abeona Therapeutics Inc
- Abeona Therapeutics Inc - Overview
- Abeona Therapeutics Inc - Product / Service
- Abeona Therapeutics Inc - Key offerings

15.24 Adaptimmune Therapeutics plc
- Adaptimmune Therapeutics plc - Overview
- Adaptimmune Therapeutics plc - Product / Service
- Adaptimmune Therapeutics plc - Key offerings

15.25 Adverum Biotechnologies Inc
- Adverum Biotechnologies Inc - Overview
- Adverum Biotechnologies Inc - Product / Service
- Adverum Biotechnologies Inc - Key offerings

15.26 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings

15.27 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings

15.28 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings

15.29 bluebird bio Inc.
- bluebird bio Inc. - Overview
- bluebird bio Inc. - Product / Service
- bluebird bio Inc. - Key offerings

15.30 Editas Medicine Inc.
- Editas Medicine Inc. - Overview
- Editas Medicine Inc. - Product / Service
- Editas Medicine Inc. - Key offerings

15.31 ElevateBio
- ElevateBio - Overview
- ElevateBio - Product / Service
- ElevateBio - Key offerings

15.32 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Product / Service
- F. Hoffmann La Roche Ltd. - Key offerings

15.33 Generation Bio Co.
- Generation Bio Co. - Overview
- Generation Bio Co. - Product / Service
- Generation Bio Co. - Key offerings

15.34 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key offerings

15.35 Novartis AG
- Novartis AG - Overview
- Novartis AG - Product / Service
- Novartis AG - Key offerings

15.36 Orchard Therapeutics Plc
- Orchard Therapeutics Plc - Overview
- Orchard Therapeutics Plc - Product / Service
- Orchard Therapeutics Plc - Key offerings

15.37 Poseida Therapeutics Inc.
- Poseida Therapeutics Inc. - Overview
- Poseida Therapeutics Inc. - Product / Service
- Poseida Therapeutics Inc. - Key offerings

15.38 Sangamo Therapeutics Inc
- Sangamo Therapeutics Inc - Overview
- Sangamo Therapeutics Inc - Product / Service
- Sangamo Therapeutics Inc - Key offerings

15.39 Sibiono GeneTech Co. Ltd.
- Sibiono GeneTech Co. Ltd. - Overview
- Sibiono GeneTech Co. Ltd. - Product / Service
- Sibiono GeneTech Co. Ltd. - Key offerings

15.40 Syncona Ltd.
- Syncona Ltd. - Overview
- Syncona Ltd. - Product / Service
- Syncona Ltd. - Key offerings

15.41 uniQure NV
- uniQure NV - Overview
- uniQure NV - Product / Service
- uniQure NV - Key offerings

15.42 Voyager Therapeutics Inc
- Voyager Therapeutics Inc - Overview
- Voyager Therapeutics Inc - Product / Service
- Voyager Therapeutics Inc - Key offerings

16 Appendix

16.1 Scope of the report

16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist

16.3 Currency conversion rates for US$
- Currency conversion rates for US$

16.4 Research methodology
- Research methodology

16.5 Data procurement
- Information sources

16.6 Data validation
- Data validation

16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing

16.8 Data synthesis
- Data synthesis

16.9 360 degree market analysis
- 360 degree market analysis

16.10 List of abbreviations
- List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES